Clinical Trials
2 trialsNCT06896890 2025-03-26
Cisplatin (CIS) Administered As Dry Powder for Inhalation (DPI) in Patients with Stage IV Non-Small Cell Lung Cancer
Inhatarget Therapeutics
Phase 1/2 Recruiting
NCT05303376 2023-09-13
Phase 1&2 Study to Evaluate the Safety & Efficacy of Inhaled IBIO123 in Severe COVID-19 Illness
Immune Biosolutions Inc
Phase 1/2 Completed